Trinity Place Holdings Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Trinity Place Holdings Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.54M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $33.60M | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | $42.98M | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | $27.27M | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | $2.43M | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | $833.0K | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | $493.0K | Oct 5, 2022 |
| FY2020 | Dec 31, 2020 | $251.0K | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | $276.0K | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $402.0K | Mar 31, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Oct 29, 2011 | $258.21M | May 25, 2012 |
| FY2011 | Feb 26, 2011 | $445.13M | May 25, 2012 |
| FY2011 | Feb 27, 2010 | $377.31M | May 25, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Oct 29, 2011 | $100.19M | May 25, 2012 |
| FY2011 | Feb 26, 2011 | $173.79M | May 25, 2012 |
| FY2011 | Feb 27, 2010 | $145.10M | May 25, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.60M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($39.02M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | ($20.69M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | ($20.81M) | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | ($3.61M) | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | ($6.43M) | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | ($7.42M) | Oct 5, 2022 |
| FY2020 | Dec 31, 2020 | ($5.40M) | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | ($5.39M) | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $20.54M | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($4.98M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($9.71M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | ($8.61M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | ($10.62M) | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | ($2.74M) | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | ($3.68M) | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | ($3.90M) | Oct 5, 2022 |
| FY2020 | Dec 31, 2020 | ($4.02M) | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | ($4.52M) | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $20.95M | Mar 31, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Oct 29, 2011 | $76.08M | May 25, 2012 |
| FY2011 | Feb 26, 2011 | $124.39M | May 25, 2012 |
| FY2011 | Feb 27, 2010 | $109.46M | May 25, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($7.94M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($5.47M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | $1.35M | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | ($21.24M) | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | ($30.80M) | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | ($22.89M) | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | ($14.08M) | Oct 5, 2022 |
| FY2022 | Dec 31, 2020 | ($55.88M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($70.63M) | Oct 5, 2022 |
| FY2020 | Dec 31, 2018 | ($2.67M) | Mar 31, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Oct 29, 2011 | $1.15M | May 25, 2012 |
| FY2011 | Feb 26, 2011 | $15.54M | May 25, 2012 |
| FY2011 | Feb 27, 2010 | $12.22M | May 25, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.73M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $267.51M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $306.93M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $341.17M | Mar 31, 2023 |
| FY2021 | Sep 30, 2021 | $340.54M | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | $332.87M | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | $327.95M | Oct 5, 2022 |
| FY2021 | Dec 31, 2020 | $323.26M | Oct 5, 2022 |
| FY2020 | Dec 31, 2019 | $345.32M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $256.76M | Mar 13, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.53M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $277.56M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $279.59M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $291.16M | Mar 31, 2023 |
| FY2021 | Sep 30, 2021 | $295.30M | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | $284.48M | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | $273.42M | Oct 5, 2022 |
| FY2021 | Dec 31, 2020 | $261.24M | Oct 5, 2022 |
| FY2020 | Dec 31, 2019 | $285.63M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $197.30M | Mar 13, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.20M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($10.05M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | $27.34M | Mar 24, 2025 |
| FY2024 | Dec 31, 2021 | $50.01M | Mar 24, 2025 |
| FY2021 | Sep 30, 2021 | $45.24M | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | $48.39M | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | $54.52M | Oct 5, 2022 |
| FY2023 | Dec 31, 2020 | $62.02M | Mar 29, 2024 |
| FY2022 | Dec 31, 2019 | $55.96M | Mar 31, 2023 |
| FY2021 | Dec 31, 2018 | $58.85M | Oct 5, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($90.30M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($95.91M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($56.89M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($36.20M) | Mar 31, 2023 |
| FY2021 | Sep 30, 2021 | ($32.85M) | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | ($29.24M) | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | ($22.81M) | Oct 5, 2022 |
| FY2021 | Dec 31, 2020 | ($15.39M) | Oct 5, 2022 |
| FY2020 | Dec 31, 2019 | ($16.00M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($15.47M) | Mar 13, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $277.0K | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $264.0K | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | $1.55M | Mar 24, 2025 |
| FY2024 | Dec 31, 2021 | $4.31M | Mar 24, 2025 |
| FY2021 | Sep 30, 2021 | $917.0K | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | $2.17M | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | $5.03M | Oct 5, 2022 |
| FY2023 | Dec 31, 2020 | $6.52M | Mar 29, 2024 |
| FY2022 | Dec 31, 2019 | $9.20M | Mar 31, 2023 |
| FY2021 | Dec 31, 2018 | $11.50M | Oct 5, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | (1) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Oct 5, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 31, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | (1) | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Oct 5, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 31, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 65.31M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | 38.20M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 36.91M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 36.63M | Mar 31, 2023 |
| FY2021 | Sep 30, 2021 | 32.62M | Oct 5, 2022 |
| FY2021 | Jun 30, 2021 | 32.46M | Oct 5, 2022 |
| FY2021 | Mar 31, 2021 | 32.44M | Oct 5, 2022 |
| FY2021 | Dec 31, 2020 | 32.17M | Oct 5, 2022 |
| FY2020 | Dec 31, 2019 | 31.88M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 31.65M | Mar 13, 2020 |